These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28657769)

  • 1. Monurelle Biogel
    Nappi RE; Cagnacci A; Becorpi AM; Nappi C; Paoletti AM; Busacca M; Martella S; Bellafronte M; Tredici Z; Di Carlo C; Corda V; Vignali M; Bagolan M; Sardina M
    Climacteric; 2017 Oct; 20(5):467-475. PubMed ID: 28657769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, tolerability and safety of a new medical device, Monurelle Biogel(®) vaginal gel, in the treatment of vaginal dryness: a randomized clinical trial in women of reproductive age.
    Nappi RE; Benedetto C; Campolo F; Martella S; Tosti C; Cianci A; Caruso S; Guaschino S; Grimaldi E; Bagolan M; Sardina M
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():82-8. PubMed ID: 27261817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study.
    De Seta F; Caruso S; Di Lorenzo G; Romano F; Mirandola M; Nappi RE
    Maturitas; 2021 May; 147():34-40. PubMed ID: 33832645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A medical device containing purified bovine colostrum (Monurelle Biogel) in the treatment of vulvovaginal atrophy in postmenopausal women: Retrospective analysis of urinary symptoms, sexual function, and quality of life.
    Schiavi MC; Di Tucci C; Colagiovanni V; Faiano P; Giannini A; D'Oria O; Prata G; Perniola G; Monti M; Zullo MA; Muzii L; Benedetti Panici P
    Low Urin Tract Symptoms; 2019 Apr; 11(2):O11-O15. PubMed ID: 29057583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel.
    Caruso S; Cianci S; Amore FF; Ventura B; Bambili E; Spadola S; Cianci A
    Menopause; 2016 Jan; 23(1):47-54. PubMed ID: 26079974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction.
    Vale F; Rezende C; Raciclan A; Bretas T; Geber S
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():92-95. PubMed ID: 30677618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors.
    Davis SR; Robinson PJ; Jane F; White S; White M; Bell RJ
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4146-4154. PubMed ID: 30239842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
    Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
    J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial.
    Mitchell CM; Reed SD; Diem S; Larson JC; Newton KM; Ensrud KE; LaCroix AZ; Caan B; Guthrie KA
    JAMA Intern Med; 2018 May; 178(5):681-690. PubMed ID: 29554173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?
    Stute P
    Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of a class II medical device based on highly purified and standardized plant extracts in the management of post-menopausal patients with vulvar and vaginal atrophy: a single-center prospective observational study.
    Galli V; Golia D'Augè T; DI Pierro F; Cazzaniga M; Guasti L; Zerbinati N; Bertuccioli A; Khan A; D'Ovidio G; Iaculli F; Tibaldi V; Santangelo G; Fischetti M; Casorelli AF; DI Donato V; Giannini A; Musella A; Giancotti A; Monti M
    Minerva Obstet Gynecol; 2024 Aug; 76(4):343-352. PubMed ID: 38358384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women.
    Cruz VL; Steiner ML; Pompei LM; Strufaldi R; Fonseca FLA; Santiago LHS; Wajsfeld T; Fernandes CE
    Menopause; 2018 Jan; 25(1):21-28. PubMed ID: 28763401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of raloxifene on sexual function in postmenopausal women.
    Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
    Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estradiol vaginal gel on vaginal atrophy in postmenopausal women: A randomized double-blind controlled trial.
    Tanmahasamut P; Jirasawas T; Laiwejpithaya S; Areeswate C; Dangrat C; Silprasit K
    J Obstet Gynaecol Res; 2020 Aug; 46(8):1425-1435. PubMed ID: 32715556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short and long-term effect of polycarbophil vaginal gel on vaginal atrophy of peri- and post-menopausal women. The TRIPLE study.
    Cagnacci A; Franco Barattini D; Casolati E; Mangrella M; Piccolo E; Piazza R; Pecoroni A; Rosu S; Cristian Pătrașcu L
    Eur J Obstet Gynecol Reprod Biol; 2024 Aug; 299():303-308. PubMed ID: 38950453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of oxytocin vaginal gel on vaginal atrophy in postmenopausal women: a randomized controlled trial.
    Zohrabi I; Abedi P; Ansari S; Maraghi E; Shakiba Maram N; Houshmand G
    BMC Womens Health; 2020 May; 20(1):108. PubMed ID: 32429977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial.
    Portman D; Palacios S; Nappi RE; Mueck AO
    Maturitas; 2014 Jun; 78(2):91-8. PubMed ID: 24679891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.
    Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA
    Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective treatment of vaginal atrophy with isoflavone vaginal gel.
    Lima SM; Yamada SS; Reis BF; Postigo S; Galvão da Silva MA; Aoki T
    Maturitas; 2013 Mar; 74(3):252-8. PubMed ID: 23312487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
    Cano A; Estévez J; Usandizaga R; Gallo JL; Guinot M; Delgado JL; Castellanos E; Moral E; Nieto C; del Prado JM; Ferrer J
    Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.